Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vannier

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
British Journal of Cancer|January 8, 2004
Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemiaN Jourdan-Da Silva, Y Perel, F Méchinaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
Bone Marrow Transplantation|June 11, 2013
Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie CellulaireC Paillard, E Rochette, P Lutz, et al.
British Journal of Haematology|August 29, 1998
Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle studyP Bordigoni, H Esperou, G Souillet, et al.
British Journal of Haematology|April 1, 1996
A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle OsseuseM Cavazzana-Calvo, P Bordigoni, G Michel, et al.
Bone Marrow Transplantation|January 24, 2017
Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)C Roux, K Tifratene, G Socié, et al.
Journal of Child Neurology|June 1, 2000
Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlationF Bernaudin, S Verlhac, F Fréard, et al.
Bone Marrow Transplantation|December 13, 2016
Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experienceA-L Alloin, G Leverger, J-H Dalle, et al.
Scientific Reports|August 20, 2017
Mineralization and Preservation of an extremotolerant Bacterium Isolated from an Early Mars Analog EnvironmentF Gaboyer, C Le Milbeau, M Bohmeier, et al.
Bone Marrow Transplantation|January 10, 2001
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)M Michallet, X Thomas, J P Vernant, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
British Journal of Cancer|January 8, 2004
Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemiaN Jourdan-Da Silva, Y Perel, F Méchinaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
Bone Marrow Transplantation|June 11, 2013
Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie CellulaireC Paillard, E Rochette, P Lutz, et al.
British Journal of Haematology|August 29, 1998
Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle studyP Bordigoni, H Esperou, G Souillet, et al.
British Journal of Haematology|April 1, 1996
A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle OsseuseM Cavazzana-Calvo, P Bordigoni, G Michel, et al.
Bone Marrow Transplantation|January 24, 2017
Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)C Roux, K Tifratene, G Socié, et al.
Journal of Child Neurology|June 1, 2000
Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlationF Bernaudin, S Verlhac, F Fréard, et al.
Bone Marrow Transplantation|December 13, 2016
Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experienceA-L Alloin, G Leverger, J-H Dalle, et al.
Scientific Reports|August 20, 2017
Mineralization and Preservation of an extremotolerant Bacterium Isolated from an Early Mars Analog EnvironmentF Gaboyer, C Le Milbeau, M Bohmeier, et al.
Bone Marrow Transplantation|January 10, 2001
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)M Michallet, X Thomas, J P Vernant, et al.
Pageof 18